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Abstract
Background: Leukocytes play a vital role in the host
defence and inflammatory systems, the latter being
responsible for the pathogenesis of a wide spectrum of
acute and chronic diseases. Green tea is a popular
beverage, which is consumed worldwide and its active
ingredients are epicatechin derivatives, which possess
distinct anti-inflammatory properties. The purpose of
this study was to investigate if a green tea extract could
enhance leukocyte function in humans.
Methods: Volunteers were asked to take 300mg of the green
tea extract daily for 14 days and the capacity of circulating
leukocytes to release both myeloperoxidase and lactoferrin
was assessed. Whole blood from volunteers was stimulated
with the bacterial peptide Formyl-Methionine-Leucine-
Phenylalanine (fMet-Leu-Phe). Myeloperoxidase an enzyme
that converts hydrogen peroxide to hypochlorous acid and is
stored and secreted from the granules of neutrophils and
monocytes and was measured as well as lactoferrin which is
an iron-binding protein stored and secreted from the neutro-
phils. In conjunction the antioxidant capacity of the blood of
the volunteers was also determined using a chemilumines-
cence method that measures the capacity of plasma to sca-
venge superoxide.
Results: After 14 days of treatment there was a significant
increase in the release of myeloperoxidase and lactoferrin
when whole blood was stimulated with fMet-Leu-Phe
(p<0.05), which activates a number of leukocytes
including mature neutrophils and monocytes. This was
mirrored by a significant increase in the total antioxidant
status after 14 days of green tea ingestion (p<0.05). After
the “wash-out” period of 4 weeks, all parameters were
consistent with those observed at the start of the trial
(day 0). Treatment with the green tea extract also caused
a slight but non-significant decrease in the number of
circulating leukocytes, but the counts remained within
published “normal” ranges for healthy human adults.
Conclusions: This study indicates that a green tea extract
when taken as a dietary supplement for 14 days can
increase the leukocyte activity and the total plasma anti-
oxidant status and may have role to play in the preven-
tion of inflammatory disease.
Keywords: green tea extract, lactoferrin, monocyte, mye-
loperoxidase, neutrophil
Introduction
In humans, both neutrophils and monocytes provide
defensive mechanisms against bacterial infections. This
defensive process requires a number of mechanisms
which can be divided into oxygen dependent and inde-
pendent pathways. The oxygen-dependent pathway is
reliant upon both the activation of NADPH oxidase, an
enzyme complex present on the plasma membrane that
converts oxygen to superoxide, and also the release of
myeloperoxidase from granules of the neutrophils or
monocytes [1–4]. Myeloperoxidase is responsible for the
conversion of hydrogen peroxide to hypochlorous acid, a
very potent oxidant [5]. The oxygen independent path-
ways are dependent upon phagocytosis, and the genera-
tion of a low pH within the phagolysosome [6]. This is
supported by granule movement, and secretion of their
contents into the phagolysosome [7]. The killing of bac-
teria is aided by many mechanisms including the binding
of iron by lactoferrin [8], which is present in the second-
ary granules of neutrophils and the direct action of lyso-
zyme on the bacterial cell. These are only two examples
of the mechanisms adopted by leukocytes, leading to
bacterial killing.
Neutrophil priming by agents such as tumour necrosis
factor (TNFα), GM-CSF (granulocyte/macrophage-colony
stimulating factor) and lipopolysaccharide [9, 10] cause a
dramatic increase in the response of these cells to an
activating species, such as the bacterial peptide analogue
Formyl-Methionine-Leucine-Phenylalanine (fMet-Leu-Phe).
The principal consequence of priming is to potentiate
superoxide anion generation, degranulation and the
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production of lipid mediators such as leukotriene B4 upon
stimulation of the neutrophil [11].
Green tea has a rich polyphenol content, of which
there are three subclasses: the flavonoidsQ1 , the flavones
and the flavonols. The major flavonols or catechins
are (-) –epigallocatechin-3-gallate, (-)-epicatechin,
(-)-epicatechin gallate, and these constitute about a
third of the dry weight of green tea. Quercitin, kaemp-
ferol, myrietin and apigenin are also present at lower
concentrations [12]. Previous research indicated that
isolated components such as epicatechin gallate and
hydrophobic components of green tea tend to inhibit
neutrophil activity [13–15]. However, previous work in
this laboratory demonstrated that a green tea extract
could prime isolated human neutrophils. This resulted
in a twofold increase in the production of superoxide
and a 5.5-fold increase in the release of myeloperoxi-
dase, following stimulation with fMet-Leu-Phe [16].
A supplementation study was designed to assess if
the immunomodulatory active components of the green
tea extract could enhance the release of both myeloper-
oxidase and lactoferrin from human leukocytes following
stimulation with fMet-Leu-Phe. There have also been sev-
eral observations that isolated neutrophils have different
properties to those found in whole blood. Some studies
report a greater expression of adhesion receptors on the
neutrophil plasma membrane upon isolation than in
whole blood [17, 18]. Since the isolation of human neu-
trophils is associated with some priming, such a proce-
dure may introduce complications when analysing the
results. One solution to avoid this would be to simply
stimulate whole blood with fMet-Leu-Phe and then quan-
titate the released myeloperoxidase and lactoferrin. This
approach is certainly not specific for neutrophils but also
for other leukocytes such as monocytes that express the
FMLP receptor and release myeloperoxidase upon stimu-
lation [19, 20], but lactoferrin is only present in exocrine
fluids and neutrophils [21]. The stimulation of whole
blood will be regarded as a measure of a total leukocyte
response.
In this study, we report the results from a supple-
mentation study that was designed to determine if the
green tea extract could enhance human leukocyte func-
tion. This was assessed by stimulating whole blood with
fMet-Leu-Phe and assessing the concentration of myelo-
peroxidase and lactoferrin released into the plasma. The
results indicated that the green tea extract does potenti-
ate leukocyte function without detrimental effects on the
white cell count.
Materials and methods
The green tea extract, was prepared into pills, each containing 100
mg of the extract and was kindly donated by Quest Vitamins Ltd
(Birmingham UK). This is a commercial product, and its release to
the public is dependent upon stringent quality control and a man-
ufacturer’s guarantee that each pill contained 60 mg of total poly-
phenols.
Subjects
Healthy subjects who were not taking any medication for any
known disease participated in the study, which had the approval
of the Ethics Committee of Liverpool John Moores University.
Informed consent was obtained from every volunteer. The cohort
consisted of 10 males and 10 females between the ages of 20–55
(mean age: 35.2 7.3). On day 0 of the trial, all the volunteers
donated 10 mL of blood to establish baseline values for lactoferrin
and myeloperoxidase release, white cell count and an indirect
measurement of water soluble antioxidant capacity. All blood
samples were obtained by venepuncture, and 9 parts of blood
were added to 1 part of 3.8% (w/v) tri-sodium citrate. Granulocyte
counts were performed using an improved Neubauer counting
chamber. The subjects then took 3 100 mg green tea extract
(Quest Vitamins Birmingham, UK) pills per day, this is the dose
recommended by manufacturer. The subjects carried out their
usual lifestyles, with no alterations in diet or alcohol intake. On
day 14, another blood sample was donated by the volunteers. All
subjects were then requested to discontinue taking the green tea
extract for a further 4 weeks after which a final blood sample was
obtained. These samples were analysed for lactoferrin, myeloper-
oxidase, white cell counts and total antioxidant status.
Whole blood was aliquoted into 2 mL minifuge tubes and phenyl-
methanesulphonyl fluoride was added (final concentration 1 mM), to
inhibit any protease activity from plasma or secreted proteases. This
was followed by the addition of fMet-Leu-Phe at a final concentra-
tion of 1 μM. The samples were incubated at 37°C for 10 min and
were then centrifuged at 13,000 rpm for 5 s. The plasma layer was
removed and stored at –80°C prior to analysis.
Enzyme immunoassay of myeloperoxidase
and lactoferrin
Following neutrophil stimulation with fMet-Leu-Phe, released con-
centrations of myeloperoxidase and lactoferrin were determined
using commercially available enzyme linked immunoassay kits
(Calbiochem, UK).
The assays were carried out in accordance with the manufac-
turer’s instructions. The participant plasma was thawed and 100 μL
aliquot was placed in duplicate into a microtitre wells previously
coated with anti-myeloperoxidase. The plate was covered and
incubated for 2 h at 37°C. The plate was then washed exten-
sively followed by the addition of 100 μL biotinylated goat anti-
myeloperoxidase. The plate was again incubated for 1 h at 37°C and
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following washing 100 μL of avidin-alkaline phosphatase was
added. This was followed by a final incubation for 1 h at 37°C
after which the substrate p-nitrophenylphosphate was added. The
reaction was allowed to proceed for 25 min at 37°C and was
stopped by the addition of a stop solution and the absorption at
405 nm was then determined. A standard curve was prepared using
serial dilutions of a myeloperoxidase standard.
A similar method was employed for lactoferrin determination,
except that the Horseradish Peroxidase linked secondary antibody
was used, and o-phenylenediamine was used as the substrate. The
coloured product 2,3-diaminophenazine was monitored at 420 nm. The
sensitivity of both assays is reported to be approximately 1 ng/mL.
Antioxidant status
Antioxidant status of the volunteers was also assessed using a
Pholasin based kit (Abel-21, Knight Scientific, Plymouth, UK). If
the volunteers had been taking the green tea supplements then
there should be an increase in antioxidant status as the green tea
extract is rich in polyphenols.
Superoxide was generated according to instructions supplied by
the kit and chemiluminescence was generated when the radical was
scavenged by pholasin. When plasma is used in conjunction with
the assay water soluble antioxidants compete with pholasin to
quench the light emitted. A reduced chemiluminescence is thus
associated with an increased antioxidant status in the plasma. The
manufacturer’s instructions were followed, and chemiluminescence
was monitored using a LKB Wallac 1251 Luminometer. The antiox-
idant capacity of the sample was expressed as % inhibition of peak
light emission.
Statistics
Results from the green tea supplementation study were analysed
using repeated measures ANOVA using the post hoc Bonferroni
correction. A p-value less than 0.05 was considered statistically
significant. All statistical tests were performed using SPSS v20.
Results
White cell count
The volunteers were healthy adults with no apparent
inflammatory diseases and reported no adverse problems
during the supplementation study. However, the green
tea extract appeared to reduce the white cell count in
some volunteers (Figure 1). Statistical treatment using a
repeated measures ANOVA indicated there was no sig-
nificant difference (p >0.05) across the three time points
and the white cell count remained within range of
4–11 109/L [22]. The mean neutrophil count at day 0
was (6.73 1.14) 109/L, at day 14 was (6.1 1.55) 109/L,
after washout period was (6.7 1.95) 109/L.
Lactoferrin and myeloperoxidase
Both myeloperoxidase and lactoferrin were measured fol-
lowing stimulation of leukocytes in whole blood by the
bacterial peptide analogue fMet-Leu-Phe. Green tea sup-
plementation for 14 days significantly increased the
release of both myeloperoxidase and lactoferrin when
compared to day 0 (12.4 2.3 vs. 15.2 4.2 ng/107 white
cells) and (16.3 2.9 vs. 23.1 4.9 ng/107 white cells)
respectively (p<0.05) (Figure 2A, B). After the washout
period, the level of myeloperoxidase (12.3 2.9 ng/107
white cells) and lactoferrin (17.6 4.2 ng/107 white
cells) release was comparable to that observed on day
0. On an individual basis the effect ranged from a modest
increase to approximately double that of the initial
response. However no increase in the release of either
lactoferrin or myeloperoxidase was observed in 15% of
the subjects.
Total antioxidant status
A separate measure to monitor the effectiveness of the
green tea supplement was to measure an increase in
water-soluble antioxidant status. This was reflected in
the results on day 14 when there was a significant
increase in total antioxidant status (p<0.05) (Figure 3)
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Figure 1: Human blood samples were taken at days 0, 14 and 42.
These were diluted, the red cells were lysed and the leukocytes were
stained and counted using an improved Neubauer counting cham-
ber. Each count was performed three times and the average was
taken. The results indicate no significant decrease in total white cell
count at day 14 or 42 compared to the baseline.
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compared to that at day 0 (Day 0, mean 9.9 2.5 vs. Day
14 mean 32 6% reduction in light emission). However,
three subjects had no increase in either myeloperoxidase,
lactoferrin release or any increase in antioxidant status.
This implies that these subjects were either not taking the
supplements in the agreed manner or did not respond to
the green tea extract. Interestingly, after the “wash-out”
period (day 42), the total antioxidant status was consis-
tent with that at the start of the supplementation study
(Day 42 mean 17.5 5% reduction in light emission). This
would indicate the increase in total antioxidant status
was largely due to the ingestion of the green tea extract.
Discussion
Previous research established that chemical constituents
in green tea extract can prime human neutrophils that
were isolated from whole blood [16] and this study indi-
cates that a similar effect exists in vivo. The twenty sub-
jects, largely responded to the treatment, and yielded an
increased release of both myeloperoxidase and lactofer-
rin, when whole blood was stimulated by the addition of
FMet-Leu-Phe. The lactoferrin release data was more con-
vincing than the myeloperoxidase. In the previous report
[16], we used an assay that recorded myeloperoxidase
activity, but in this study we used an immunological
assay, and this may have contributed to this lack of
discrimination with the myeloperoxidase data. This may
be due to reactive oxygen species such as hypochlorous
acid destroying antigenic sites on the enzyme. However
the paired t-test data indicates that there was a signifi-
cant difference between day 0 and day 14. This would
suggest that if these volunteers encountered a bacterial
infection whilst taking the green tea extract supplements,
they may be able to mount an improved immunological
response. The neutrophils in the supplemented volun-
teers would respond more effectively to bacterial pep-
tides, have enhanced NADPH oxidase activity along
with the enhanced release of myeloperoxidase inducing
the formation of hypochlorous acid which can kill Gram-
positive bacteria and an increased release of lactoferrin
which chelates iron so helping to prevent the growth of
bacterial species [23].
Several studies [10, 12, 14, 15] indicate that (-) epigal-
locatechin-3-gallate inhibit neutrophil function. The main
0
5
10
15
20
25
30
Day 0 Day 14
(A)
(B)
Day 42
L
ac
to
fe
rr
in
 (
n
g
/1
07
) 
 w
h
it
e
ce
lls
 
Lactoferrin Release of Whole Blood 
Following Stimulation with fMet-Leu-
Phe
0
5
10
15
20
25
Day 0  Day 14 Day 42
M
ye
lo
p
er
o
xi
d
sa
e 
(n
g
/1
07
) 
w
h
it
e 
ce
lls
Myeloperoxidase Release in whole 
Blood Following Stimulation with 
fMet-Leu-Phe
*
*
Figure 2: Neutrophils in human whole blood were stimulated by the
addition of fMet-Leu-Phe.
Plasma was obtained, and the release of (A) lactoferrin and (B)
myeloperoxidase was assessed by immunoassay. The results indi-
cate baseline measurements at day 0, significant increases at day
14 (p<0.05). Following a washout period, the levels of lactoferrin
and myeloperoxidase release were comparable to those observed at
baseline.
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Figure 3: The total antioxidant activity of human plasma was deter-
mined by a chemiluminescence assay.
The plasma competes for chemically generated radicals, a reduction
in chemiluminescence being regarded as having distinct antioxidant
properties. The results indicate baseline measurements at day 0,
significant increases in antioxidant activity at day 14 (p<0.05).
Following a washout period, the release was similar to baseline
measurements.
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argument for this is that epicatechins inhibit neutrophil
chemotaxis both in vitro and in vivo situations. This has
been reported as a direct effect on neutrophils and an in-
direct effect on the inhibition of synthesis of chemokines
by fibroblasts. Many of these studies were performed
using rat blood [24, 25] or cell culture [26, 27] with a
relatively short contact time of the epicatechin or green
tea extract. In contrast to these studies it was recently
reported that (-)-epicatechin may enhance the efficiency
of myeloperoxidase in the presence of higher concentra-
tions of hydrogen peroxide which would enhance the
immune response to bacterial infections [28]. With regard
to action of the NADPH oxidase the majority of the stu-
dies examined the antioxidative effects of the green tea
extract rather than its priming properties [29, 30]. The
present study employed a green tea extract over a 14
day period a rather short-term experiment, the in vivo
observations could be explained by either a direct or an
indirect action of the extract. The green tea extract used
in this study is a complex mixture and it is possible that a
synergistic action of some of the ingested components
resulted in the observed priming effect. Efferth [31]
reports that different components found in complex her-
bal mixtures may act at different points in the same
signalling pathway (multi-target effects) to enhance
observed effects.
There was a minor decrease in the total white cell
count, at day 14 in some individuals (Figure 1). The
most extreme case was reduction from 6.8 109/l to
4.8 109/l. This represented a 30% decrease, but the
count was still within the normal range [22]. Ex vivo and
in vitro studies indicated that green tea extract had very
distinct leukocyte priming properties [12, 16]. In this case
the green tea extract was delivered as a pill, with each
containing 60 mg of polyphenols. The bioavailability of
green tea extract in this form was previously investigated
[32], the study investigated uptake and plasma antioxidant
status following one dose of green tea as a beverage or as
a gelatin capsule. It was found that the absorption of
polyphenols from the green tea supplement in a gelatin
capsule was delayed but was higher than that of green tea
or black tea beverages. The supplement also increased the
total plasma antioxidant status 2–3% greater than the
beverages over an eight hour period. This study indicates
that that green tea extract in a pill form is an efficient way
of increasing polyphenols in the plasma.
The priming effect of the green tea extract may thus
benefit the very young and the elderly against bacterial
infections. However it could be argued that ingestion of
the green tea extract may potentiate any inflammatory
diseases such as periodontitis or rheumatoid arthritis
diseases which involve leukocyte infiltration and activa-
tion [33, 34]. It has been suggested that immunoglobulins
and other cytokines may prime these leukocytes, at sites
of inflammation [35]. Green tea extract would not make
any significant contribution to the inflammatory process,
as priming of mature neutrophils in synovial fluid is a
very efficient process. This could be the result of the
presence of high levels of priming agents such as TNFα
and IL-8 but not GM-CSF in the inflamed joint [36].
This small study suggests that green tea extract
can potentiate neutrophil function through priming.
Stimulation of primed neutrophils by bacteria would
enhance degranulation and superoxide production.
Previous work suggests that the in vitro priming proper-
ties of the green tea extract were approximately 50% of
GM-CSF. Unlike GM-CSF the mechanism of green tea
priming did not involve tyrosine kinase activation [16].
However, further work is needed to elucidate the compo-
nents of the green tea extract and mechanisms that are
responsible for the priming of mature human leukocytes.
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